|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.926 EUR | +0.47% |
|
-9.55% | +8.73% |
| 13/01 | Evotec says Michael Kaufman holds 5.03% of total voting rights and instruments in Evotec | RE |
| 08/01 | Evotec Receives Gates Foundation Grant to Deploy AI in Optimizing Monoclonal Antibodies | MT |
Chart calendar Evotec SE
Upcoming events on Evotec SE
| 01/04/2026 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 13/05/2026 | Q1 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 19/08/2026 | Q2 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 11/11/2026 | Q3 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
Past events on Evotec SE
| 16/12/2025 | British Pharmacological Society Conference |
| 11/12/2025 | Dutch Life Science Conference |
| 11/12/2025 | PSC Derived Therapies Symposium |
| 10/12/2025 | Drug Delivery to the Lungs Conference |
| 03/12/2025 | Berenberg European Conference |
| 02/12/2025 | Cell Therapy for Autoimmune Disease Summit |
| 01/12/2025 | Cell & Gene Therapy International Europe Conference |
| 24/11/2025 | German Equity Forum |
| 20/11/2025 | Spanish Drug Discovery Network Meeting |
| 18/11/2025 | EBF Open Symposium |
| 16/11/2025 | American College of Toxicology Meeting |
| 15/11/2025 | SfN Neuroscience Conference |
| 13/11/2025 | Next GEN OMICS & Data Conference |
| 11/11/2025 | PEGS Europe Conference |
| 10/11/2025 | Biomanufacturing World Summit |
| 09/11/2025 | Human Proteome Organization Conference |
| 05/11/2025 | Q3 2025 Earnings Call |
| 05/11/2025 | Q3 2025 Earnings Release |
| 05/11/2025 | Rescon Conference |
| 05/11/2025 | Society for Immunotherapy of Cancer Conference |
Annual results
| Fiscal Period | December | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 751 738 1.86% | 781 780 0.24% | 797 797 -0.01% | 781 | 840 | 930 |
|
EBITDA Million EUR | Released Forecast Spread | 102 104 -2.29% | 66,4 69,4 -4.34% | 22,6 14,5 55.81% | 32,4 | 86,7 | 147 |
|
EBIT Million EUR | Released Forecast Spread | 20,9 21,0 -0.93% | -26,6 -37,8 29.48% | -143 -142 -0.64% | -66,2 | -18,4 | 47,6 |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -154 -126 -21.99% | -80,6 -60,1 -34.12% | -194 -185 -4.62% | -84,9 | -36,3 | 43,9 |
|
Net income Million EUR | Released Forecast Spread | -176 -136 -28.92% | -83,9 -54,7 -53.55% | -196 -142 -37.66% | -77,3 | -28,2 | 40,3 |
|
EPS EUR | Released Forecast Spread | -0,99 -0,68 -45.54% | -0,47 -0,30 -54.57% | -1,11 -0,75 -47.61% | -0,37 | -0,14 | 0,14 |
| Announcement Date | 12/05/23 | 24/04/24 | 17/04/25 | - |
Quarterly results
| Fiscal Period | September | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 209 202 3.15% | 182 209 -12.89% | 391 393 -0.55% | 185 192 -3.56% | 221 220 0.71% | 200 215 -7.02% | 171 195 -12.34% | 164 191 -14.11% | 240 | 203 | 185 | 167 | 227 |
|
EBITDA Million EUR | Released Forecast Spread | 7,82 15,9 -50.85% | -8,28 12,4 -166.7% | -0,47 9,10 -105.13% | -5,50 4,06 -235.57% | 28,5 22,2 28.79% | 3,11 10,0 -69.04% | -4,96 7,49 -166.17% | -15,0 7,74 -294.19% | 43,0 | ||||
|
EBIT Million EUR | Released Forecast Spread | -14,7 -9,64 -52.92% | -36,2 -9,87 -266.38% | -26,5 -21,1 -25.33% | 6,78 -12,3 155.38% | -28,6 -19,4 -47.72% | -44,5 -20,7 -115.28% | 14,2 | -7,20 | -4,80 | ||||
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -26,8 -11,7 -129.31% | -104 -13,5 -674.86% | -46,9 -26,0 -80.16% | -15,9 -13,2 -20.48% | -43,4 -13,7 -216.33% | -43,0 -24,0 -79.24% | 10,8 | -25,2 | -22,8 | ||||
|
Net income Million EUR | Released Forecast Spread | -20,7 -19,4 -6.63% | -94,9 -17,4 -445.63% | -39,6 -23,1 -71.34% | -40,8 -13,2 -210.11% | -31,6 -28,0 -12.7% | -43,5 -22,7 -91.5% | -43,1 -30,0 -43.65% | 12,6 | -26,2 | -23,7 | |||
|
EPS EUR | Released Forecast Spread | -0,12 -0,07 -71.43% | -0,54 -0,14 -285.71% | -0,22 -0,14 -57.14% | -0,18 | -0,24 -0,13 -84.62% | ||||||||
| Announcement Date | 22/05/24 | 14/08/24 | 14/08/24 | 06/11/24 | 17/04/25 | 06/05/25 | 13/08/25 | 05/11/25 | - | - | - | - | - |
| 23/01/2026 | Q3 2026 Earnings Release | Add to your calendar Google Apple ICS format | |
| 28/01/2026 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format | |
| 29/01/2026 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format | |
| 04/02/2026 | Q3 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 04/02/2026 | Q2 2026 Earnings Release | Add to your calendar Google Apple ICS format | |
| 05/02/2026 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format | |
| 05/02/2026 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format | |
| 09/02/2026 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format | |
| 11/02/2026 | Q1 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 12/02/2026 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
Past sector events for Evotec SE
| Today | Q3 2026 Earnings Release | |
| 20/01/2026 | Q4 2025 Earnings Release | |
| 16/01/2026 | Q2 2026 Sales and Revenue Release - Trading Update | |
| 12/01/2026 | December 2025 Sales and Revenue Release | |
| 09/01/2026 | December 2025 Sales and Revenue Release | |
| 08/01/2026 | December 2025 Sales and Revenue Release | |
| 24/12/2025 | Q4 2025 Earnings Release | |
| 16/12/2025 | Q3 2025 Earnings Release | |
| 12/12/2025 | Q3 2025 Earnings Release | |
| 10/12/2025 | November 2025 Sales and Revenue Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- EVT Stock
- Calendar Evotec SE
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















